McGowan Group Asset Management’s Merck MRK Stock Holding History

McGowan Group Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-118,102	Closed	-$11.7M	–	128
2024 Q4	$11.7M	Buy	118,102 +654	+0.6%	+$67.4K	1.57%	22
2024 Q3	$13.3M	Sell	117,448 -50,702	-30%	-$6.02M	1.76%	20
2024 Q2	$20.8M	Sell	168,150 -252	-0.1%	-$32.5K	2.9%	12
2024 Q1	$22.2M	Sell	168,402 -1,845	-1%	-$227K	3.2%	9
2023 Q4	$18.6M	Sell	170,247 -3,578	-2%	-$371K	2.98%	13
2023 Q3	$17.9M	Sell	173,825 -614	-0.4%	-$66.2K	2.83%	13
2023 Q2	$20.1M	Sell	174,439 -77	-0%	-$8.74K	3.14%	8
2023 Q1	$18.6M	Sell	174,516 -1,446	-0.8%	-$156K	2.95%	11
2022 Q4	$19.5M	Buy	175,962 +3,163	+2%	+$323K	3.11%	9
2022 Q3	$14.9M	Buy	172,799 +520	+0.3%	+$46.4K	2.58%	15
2022 Q2	$15.7M	Buy	172,279 +13,585	+9%	+$1.2M	2.63%	13
2022 Q1	$13M	Buy	158,694 +140,138	+755%	+$11M	2%	13
2021 Q4	$1.42M	Buy	18,556 +13,927	+301%	+$1.11M	0.25%	44
2021 Q3	$348K	Buy	4,629 +30	+0.7%	+$2.28K	0.06%	80
2021 Q2	$358K	Sell	4,599 -320	-7%	-$23.8K	0.06%	82
2021 Q1	$362K	Sell	4,919 -248	-5%	-$18.3K	0.06%	77
2020 Q4	$403K	Buy	5,167 +163	+3%	+$12.5K	0.07%	70
2020 Q3	$396K	Buy	5,004 +123	+3%	+$9.63K	0.08%	66
2020 Q2	$360K	Buy	4,881 +29	+0.6%	+$2.18K	0.07%	70
2020 Q1	$356K	Buy	4,852 +2	+0%	+$157	0.08%	59
2019 Q4	$421K	Buy	4,850 +3	+0.1%	+$246	0.07%	68
2019 Q3	$389K	Sell	4,847 -150	-3%	-$12K	0.06%	70
2019 Q2	$400K	Buy	4,997 +82	+2%	+$6.28K	0.06%	82
2019 Q1	$390K	Buy	4,915 +111	+2%	+$8.3K	0.06%	84
2018 Q4	$350K	Buy	4,804 +2	+0%	+$141	0.06%	82
2018 Q3	$325K	Buy	4,802 +3	+0.1%	+$191	0.05%	86
2018 Q2	$278K	Buy	4,799 +4	+0.1%	+$226	0.05%	90
2018 Q1	$249K	Sell	4,795 -1	-0%	-$54	0.04%	90
2017 Q4	$257K	Buy	4,796 +21	+0.4%	+$1.16K	0.04%	89
2017 Q3	$292K	Buy	4,775 +2	+0%	+$121	0.06%	75
2017 Q2	$292K	Buy	4,773 +4	+0.1%	+$243	0.06%	72
2017 Q1	$289K	Sell	4,769 -58	-1%	-$3.52K	0.06%	76
2016 Q4	$271K	Buy	4,827 +3	+0.1%	+$176	0.06%	78
2016 Q3	$287K	Buy	4,824 +3	+0.1%	+$175	0.06%	83
2016 Q2	$265K	Buy	4,821 +38	+0.8%	+$2.02K	0.05%	100
2016 Q1	$242K	Buy	4,783 +80	+2%	+$3.92K	0.05%	110
2015 Q4	$237K	Sell	4,703 -102	-2%	-$5.14K	0.05%	121
2015 Q3	$226K	Buy	4,805 +3	+0.1%	+$159	0.04%	128
2015 Q2	$261K	Buy	4,802 +2	+0%	+$112	0.05%	116
2015 Q1	$263K	Buy	4,800 +315	+7%	+$17.8K	0.05%	111
2014 Q4	$243K	Buy	+4,485	New	+$250K	0.05%	144

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

McGowan Group Asset Management's MRK Position: Q1 2025 in Review

McGowan Group Asset Management sold out of Merck (MRK) in Q1 2025, closing a stake of 118,102 shares — an estimated $11.7M sold.

McGowan Group Asset Management first reported a position in MRK in Q4 2014 and held it in 41 quarters. The position peaked at $22.2M in Q1 2024. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

McGowan Group Asset Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
McGowan Group Asset Management sold 118,102 Merck shares in Q1 2025, an estimated $11.7M.
McGowan Group Asset Management first reported a position in Merck in Q4 2014 and held it in 41 quarters.
McGowan Group Asset Management's Merck position peaked at $22.2M in Q1 2024.
3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on McGowan Group Asset Management's 13F filing for Q1 2025, filed 15 May 2025.